AzTrials
AzTrials

AnesthesiaHypnose2NCT02249364

Hypnosis Before the Induction of Anesthesia

A study testing Hypnosis and propofol in people with Anesthesia, run by Hopital Foch at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Hypnosis may reduce patient anxiety. The main goal of this study is to determine in what extent, hypnosis decreases propofol requirement to induce induction of general anesthesia. Read more about this study

Who is it for?
Ages 18 years and older, women only
Conditions the study is for
Anesthesia
What is being tested?
Hypnosis and propofol
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
1 siteFrance
Study dates
Apr 2014to Dec 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adult female patients scheduled for a one day gynecological surgical procedures under general anesthesia

Who cannot join

  • pregnancy, breast feeding woman
  • allergy to propofol, soy or peanuts
  • history of central nervous system disease
  • psychiatric affection
  • hypovolemia, high cardiovascular risk
  • patients with a pace-maker

Trial locations and contacts

1 site in 1 country.

France1 site
  • Dept of Anesthesia, Hôpital Foch

    Suresnes, 92150

Other trials in France

About this study

Official title: Interest of Hypnosis Before the Induction of Anesthesia. Study in Women Submitted to One Day Gynecological Surgical Procedures

Hypnosis may reduce patient anxiety. The main goal of this study is to determine in what extent, hypnosis decreases propofol requirement to induce induction of general anesthesia.

Two particular aspects of this study are

  • the inclusion of women undergoing one day gynecological surgical procedures
  • the use of a closed-loop system which delivers propofol according to bispectral index to provide induction of anesthesia.
Conditions
Anesthesia
Being tested
Control, Hypnosis, propofol

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ControlProcedure or surgery

    Routine practice

  • HypnosisProcedure or surgery

    Hypnosis session before induction of anesthesia

  • propofolDrug

    Closed-loop administration of propofol for anesthesia induction

Study groups in NCT02249364
Study groupRoleWhat they receive
ControlActive comparatorStandard care without hypnosis session followed by closed-loop administration of propofol for anesthesia induction
Receives: Procedure: Control; Drug: propofol
HypnosisExperimentalHypnosis session followed by closed-loop administration of propofol for anesthesia induction
Receives: Procedure: Hypnosis; Drug: propofol

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Administered dose of propofol

    Administered dose of propofol required to obtain the induction of anesthesia (bispectral index <60 for at least 30 seconds)

    Measured: one hour

Secondary outcomes (11)
  1. Target plasma concentration of propofol

    Target plasma concentration of propofol corresponding to induction of anesthesia (bispectral index <60 for at least 30 seconds)

    Measured: one hour

  2. Pain of insertion of peripheral vein catheter

    Pain is assessed by two criteria:

    • withdrawal of the arm perfused (no = 0; withdrawal = 1; violent withdrawal = 2),
    • spontaneous expression (no = 0; frown = 1; grin or verbal complaint = 2)

    Measured: one hour

  3. Pain due to injection of propofol

    Pain is assessed by two criteria:

    • withdrawal of the arm perfused (no = 0; withdrawal = 1; violent withdrawal = 2),
    • spontaneous expression (no = 0; frown = 1; grin or verbal complaint = 2)

    Measured: one hour

  4. Effect of hypnosis on bispectral index

    Effect of hypnosis on bispectral index before the induction of anesthesia

    Measured: one hour

  5. Time to loss of consciousness

    Time between the beginning of injection of propofol and the loss of eyelash reflex

    Measured: one hour

  6. Hemodynamic consequences of induction of anesthesia

    Heart rate and blood pressure are measured just before induction of anesthesia and once it is realized.

    Measured: one hour

  7. Administration of a cardio-vascular agent

    Administration of ephedrine, atropine or of an hypotensive agent

    Measured: one hour

  8. Manipulation of the airway

    Necessity of a jaw thrust maneuver or of another manipulation of the airway during the induction of anesthesia

    Measured: one hour

  9. Characteristics of the hypnotic procedure evaluated by the clinician in the group "hypnosis"

    The hypnotic procedure is assessed by three criteria:

    • receptivity of the patient (yes/no),
    • rapidity of focalization procedure (very fast, fast, medium, delayed, impossible to obtain),
    • quality of the hypnotic trance (very deep, deep, medium, superficial, not obtained).

    Measured: one hour

  10. Characteristics of the hypnotic procedure evaluated by the patient in the group "hypnosis"

    The hypnotic procedure is assessed by a question : "Did you visualize the memory we talked about before the session ? (yes, no )

    Measured: six hours

  11. Characteristics of the preanesthetic management evaluated by the patient (all the patients)

    The preanesthetic management is assessed by one criteria:"How do you rate the quality of the preanesthetic period (from the entrance in the operating room to the induction of the general anesthesia ?" (excellent, good, average, not good)

    Measured: Six hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Sep 2014 (estimated)
  2. Study startApr 2014
  3. Primary completionDec 2015
  4. Study completionDec 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
80 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02249364
Sponsor's protocol ID
2013/49
Other IDs
2013-A01640-45
Acronym
Hypnose2
Status last verified
Oct 2016
First submitted
23 Sep 2014
Last updated
31 Oct 2016
Results posted
No
Data monitoring committee
No

Publications

  • Liu N, Chazot T, Genty A, Landais A, Restoux A, McGee K, Laloe PA, Trillat B, Barvais L, Fischler M. Titration of propofol for anesthetic induction and maintenance guided by the bispectral index: closed-loop versus manual control: a prospective, randomized, multicenter study. Anesthesiology. 2006 Apr;104(4):686-95. doi: 10.1097/00000542-200604000-00012.

    PubMed 16571963
  • Bataille A, Guirimand A, Szekely B, Michel-Cherqui M, Dumans V, Liu N, Chazot T, Fischler M, Le Guen M. Does a hypnosis session reduce the required propofol dose during closed-loop anaesthesia induction?: A randomised controlled trial. Eur J Anaesthesiol. 2018 Sep;35(9):675-681. doi: 10.1097/EJA.0000000000000751.

    PubMed 29210845

Questions about this trial

What is this clinical trial studying?

A study testing Hypnosis and propofol in people with Anesthesia, run by Hopital Foch at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 31 Oct 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Administered dose of propofol (time frame: one hour). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02249364, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Oct 2016; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in